Search

everythinglearnresearchcommunity

for

Search:↓

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Immunoadsorption successfully treated a man's resistant polymyositis.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Enhancing Tregs can protect against alopecia areata.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Blocking certain proteins on immune cells may help treat alopecia areata.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Blocking interferon-gamma might help treat various autoimmune diseases.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.